Sample Solution

Table3 shows the outcome of 80 patients (40 in each group) included in the study.
Out of 40 patients in group Ormeloxifene, 30 patients attained amenorrhea, 8 patients symptomatically improved, 2 patients underwent hysterectomy.
Out of 40 patients in group LNG IUCD, 32 patients attained amenorrhea, 4 patients symptomatically improved, 3 patients lost to follow up, 1 patient underwent hysterectomy.

DISCUSSION
Medical management has always been the first therapeutic option to be tried and if the results fail, one can resort to surgical interventions. Medical treatment of menorrhagia should aim to relieve symptoms, improve quality of life and to avoid the risk of surgery.
The present study was conducted to evaluate the efficacy and safety of oral ormeloxifene and levonorgesterol IUCD in the management of dysfunctional uterine bleeding.
Our study included patients with menorrhagia in the age group 31-50years attending the outpatient department or admitted as inpatients in the department of obstetrics and gynecology at Sri Siddhartha Medical College and Research Centre, Tumkur.
Patients were divided into 2 groups of ormeloxifene and levonorgesterol IUCD. Patients were followed up for 6 months. Pre and post treatment outcome measures in both groups studied were as follows.
– Pre treatment and post treatment assessment of menstrual blood loss objectively by pictorial blood loss assessment chart.
– Blood hemoglobin levels
– Endometrial thickness ( transvaginal scan).
Among 80 patients included in the study, two groups contained 40 patients each. Out of 40 who were treated with oral ormeloxifene, 30 patients attained amenorrhea, 2 patients underwent hysterectomy, 8 patients symptomatically improved. Out of 40 patients treated with levonorgesterol IUCD , 32 patients attained amenorrhea, 1 patient underwent hysterectomy, 4 patients symptomatically improved and 3 patients lost to follow up.